S

    Sophia Genetics SA (SOPH)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $8.40
    +0.26 (+3.19%)

    Market Cap: $692.94M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    76%(16/21)
    Avg Surprise
    +5.39%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.20
    Range$-0.20 - $-0.20
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$-0.19+5.0%
    60d ago$-0.19+5.0%
    30d ago$-0.19+5.0%
    7d ago$-0.19+5.0%
    Current$-0.20
    Revenue Consensus
    $24M
    Range$23M - $25M
    5 analysts
    Dec 31, 2026
    EPS Consensus$-0.19
    Range$-0.19 - $-0.19
    1 analysts
    Revenue Consensus
    $29M
    Range$29M - $30M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.19---
    Sep 26EST
    		-$-0.20---
    Jun 26
    		$-0.26$-0.15-73.33%Miss-4.0%
    Mar 26
    		$-0.19$-0.24+20.83%Beat-5.6%
    Dec 25
    		$-0.17$-0.22+22.41%Beat-42.4%
    Sep 25
    		$-0.20$-0.20+0.00%Beat+4.8%
    Jun 25
    		$-0.25$-0.17-47.06%Miss-66.7%
    Mar 25
    		$-0.18$-0.19+5.26%Beat-28.6%
    Dec 24
    		$-0.12$-0.15+20.07%Beat+67.6%
    Sep 24
    		$-0.21$-0.18-16.67%Miss-50.0%
    Jun 24
    		$-0.15$-0.20+25.00%Beat+40.0%
    Mar 24
    		$-0.14$-0.21+33.33%Beat+46.2%
    Dec 23
    		$-0.37$-0.27-37.04%Miss-68.2%
    Sep 23
    		$-0.14$-0.24+41.67%Beat+61.1%
    Jun 23
    		$-0.25$-0.26+3.85%Beat+19.4%
    Mar 23
    		$-0.26$-0.28+7.14%Beat+23.5%
    Dec 22
    		$-0.22$-0.36+38.89%Beat+21.4%
    Sep 22
    		$-0.36$-0.36+0.00%Beat-20.0%
    Jun 22
    		$-0.31$-0.39+20.51%Beat+0.0%
    Mar 22
    		$-0.34$-0.30-13.33%Miss-30.8%
    Dec 21
    		$-0.28$-0.36+22.22%Beat-6.1%
    Sep 21
    		$-0.30$-0.37+18.92%Beat-9.2%
    Jun 21
    		$-0.31$-0.39+20.51%Beat-
    Mar 21
    		$-0.26$0.00N/AMiss-
    Dec 20
    		$-0.26$0.00N/AMiss-
    Dec 19
    		$-0.27$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-10.24EV/EBITDA-0.30x
    Price/FCF-13.59xFCF Yield-7.36%
    Profitability
    Profit Margin-93.90%Operating Margin-86.00%
    ROE-101.20%ROIC-55.51%
    Financial Health
    Debt/Equity0.61xInterest Coverage-11.22x
    Current Ratio2.69xQuick Ratio2.55x
    Trading Statistics
    Beta0.92Avg Volume581.54K
    52-Week High$8.9852-Week Low$3.10

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$8.40
    SMA 20$7.86
    SMA 50$6.58
    SMA 200$5.29
    EMA 10$8.29
    EMA 20$7.83
    EMA 50$6.88
    EMA 200$5.45

    MACD

    Line: 0.62Signal: 0.62Hist: -0.01

    ADX

    ADX: 46.5+DI: 28.5-DI: 10.8

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down4.0
    PSAR$8.96

    Bollinger Bands

    Upper Band$9.25
    Lower Band$6.46
    %B Position3559%(Upper)
    Band Width0.69

    RSI (14-Day)

    Neutral
    62.2

    Momentum Oscillators

    Stoch %K69.4
    Stoch %D79.2
    Williams %R-36.0
    ROC (10d)10.1%
    Momentum0.77
    CCI (20d)58.5
    MFI (14d)74.4

    Volatility Measures

    ATR (14d)$0.49(5.8%)
    StdDev (20d)0.70
    Hist Vol107.1%(High)

    Volume Flow

    VWAP$8.31
    OBV11.9M
    AD Line6.7M
    CMF (20d)0.380

    Volume Metrics

    Avg Vol (20d)592.3K
    Vol Ratio1.3x
    VWMA (20d)$7.82

    Pivot Points

    R3$9.53
    R2$9.22
    R1$8.68
    Pivot Point$8.37
    S1$7.83
    S2$7.52
    S3$6.98

    Advanced Oscillators

    TSI36.73
    Ultimate Osc57.2
    KST385.37

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$23.31M$21.69M$21.71M$19.46M$18.32M$17.78M$17.73M$15.85M$15.81M$15.78M$17.05M$16.30M
    Cost of Revenue$8.25M$6.94M$7.01M$6.55M$6.05M$5.57M$5.63M$5.20M$5.03M$5.37M$5.15M$5.03M
    Gross Profit$15.06M$14.75M$14.69M$12.91M$12.27M$12.21M$12.10M$10.65M$10.78M$10.40M$11.90M$11.27M
    Operating Expenses$35.11M$32.03M$32.74M$30.77M$30.83M$28.24M$29.55M$26.02M$25.78M$29.16M$30.85M$27.82M
    R&D$8.73M$11.06M$8.54M$9.40M$8.49M$9.12M$9.14M$7.87M$7.96M$9.39M$9.76M$8.98M
    SG&A$15.20M$13.76M$22.04M$13.89M$12.30M$11.60M$12.66M$10.88M$10.58M$12.82M$13.27M$12.75M
    Operating Income$-20,053,000$-17,283,000$-18,049,000$-17,862,000$-18,558,000$-16,036,000$-17,444,000$-15,363,000$-15,005,000$-18,756,000$-18,947,000$-16,544,000
    Interest Income$231,000$289,000$381,000$622,000$419,000$450,000$1.89M$267,000$450,000$758,000$0$0
    Interest Expense$1.62M$1.67M$1.67M$1.66M$559,000$659,000$1.91M$2.94M$501,000$143,000$5.11M$0
    Income Before Tax$-22,278,000$-19,069,000$-19,574,000$-19,379,000$-21,652,000$-16,882,000$-14,542,000$-18,308,000$-15,032,000$-13,388,000$-24,053,000$-13,525,000
    Income Tax Expense$78,000$253,000$-395,000$642,000$762,000$503,000$616,000$130,000$161,000$316,000$8,000$299,000
    Net Income$-22,356,000$-19,322,000$-19,179,000$-20,021,000$-22,414,000$-17,385,000$-15,158,000$-18,438,000$-15,193,000$-13,704,000$-24,061,000$-13,824,000
    EBITDA$-17,751,000$-14,651,000$-15,463,000$-17,243,000$-18,723,000$-13,926,000$-7,946,000$-16,095,000$-12,494,000$-11,186,000$-20,047,000$-11,324,000
    EBIT$-20,658,000$-17,402,000$-17,901,000$-18,338,000$-21,093,000$-16,223,000$-10,233,000$-18,308,000$-14,531,000$-13,245,000$-22,028,000$-13,525,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SOPH

    Government Contracts

    Gov Obligations (TTM)
    $1.12M
    Gov Obligations / Revenue
    1.4%
    Obligations YoY
    N/A
    Active Awards
    1
    New Awards (TTM)
    1
    Avg Remaining Term
    1.8 mo

    Top agency: Department of Defense at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    HT940825CE005Department of DefenseDefense Health Agency$1.12MSep 30, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    AWM Investment Company Inc. Makes New $9.81 Million Investment in SOPHiA GENETICS SA $SOPH

    AWM Investment Company Inc. has made a new $9.81 million investment in SOPHiA GENETICS SA, purchasing 1,700,000 shares. This makes AWM Investment Company Inc. a 2.03% stakeholder in the company. Other institutional investors have also recently modified their holdings in SOPHiA GENETICS, and several insiders have sold shares.

    MarketBeat•8/26/26•
    Neutral

    SOPHiA GENETICS (NASDAQ: SOPH) director plans $158K stock sale

    SOPHiA GENETICS director Kathy L. Hibbs has filed a notice under Rule 144 to sell up to 18,750 shares of common stock through Morgan Stanley Smith Barney LLC. The planned sale, with an approximate date of August 25, 2026, has an aggregate market value of $158,437.50. The shares are related to Restricted Stock Units dated June 18, 2025, and the company has 85,127,825 shares outstanding.

    Stock Titan•8/25/26•
    Neutral

    SOPHiA GENETICS (NASDAQ: SOPH) officer may sell founder shares

    SOPHiA GENETICS (NASDAQ: SOPH) officer Zhenyu Xu has filed a Form 144 notice indicating plans to sell up to 6,000 shares of common stock, identified as founder shares, through Morgan Stanley Smith Barney LLC on or after August 20, 2026. The filing also details several past 10b5-1 sales by Xu over the last three months, ranging from 3,000 to 17,000 shares. The aggregate market value of the planned sale is $49,680.00, and the founder shares were originally acquired on June 20, 2012.

    Stock Titan•8/20/26•
    Neutral

    SOPHiA GENETICS (NASDAQ: SOPH) officer lines up 10,000-share sale

    SOPHiA GENETICS officer Manuela Valente has filed a Form 144, indicating her intent to sell 10,000 shares of common stock. These shares will be acquired through the exercise of stock options for cash and sold via Morgan Stanley Smith Barney LLC on August 19, 2026, on NASDAQ. The filing also notes a prior Rule 10b5-1 sale of 4,241 shares on July 6, 2026.

    Stock Titan•8/19/26•
    Somewhat-Bearish

    SOPHiA GENETICS (NASDAQ: SOPH) officer plans additional 8,000-share sale

    An officer at SOPHiA GENETICS (NASDAQ: SOPH), Zhenyu Xu, intends to sell an additional 8,000 shares of common stock under Rule 144, valued at $60,960. These shares are founder shares acquired in 2012 and are held at Morgan Stanley Smith Barney LLC Executive Financial Services. The filing also details prior sales made by Xu over the past three months under a Rule 10b5-1 trading plan.

    Stock Titan•8/19/26•
    Neutral

    Frequently Asked Questions About SOPH

    Does SOPH pay dividends?
    Sophia Genetics SA (SOPH) does not currently pay a regular dividend.
    What is SOPH's market cap?
    Sophia Genetics SA (SOPH) has a market capitalization of $692.94M with a current stock price of $8.40.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In